News
-
-
PRESS RELEASE
Amoéba and Koppert continue to prepare the commercial launch of AXPERA, the biocontrol product developed by Amoéba.
Amoéba to continue preparing for commercial launch of biocontrol solution AXPERA with Koppert, following successful authorisations. Company aims to meet market expectations for innovative biocontrol solutions -
-
-
-
PRESS RELEASE
Amoéba obtient une dérogation exceptionnelle aux Pays-Bas pour son produit de biocontrôle AXPERA pour des essais à grande échelle en serre
Amoéba obtient une autorisation exceptionnelle aux Pays-Bas pour son produit de biocontrôle AXPERA sur plusieurs cultures sous serre, permettant la consommation des récoltes -
PRESS RELEASE
Amoéba obtains an exceptional exemption in the Netherlands for its biocontrol product AXPERA for large-scale greenhouse trials
Amoéba obtained authorisation for trials of AXPERA in the Netherlands, allowing consumption of treated crops. The Dutch greenhouse market is a strategic showcase for showcasing AXPERA's value in biocontrol fungicide -
-
-
PRESS RELEASE
New strategic milestone for Amoéba: Axpéra biocontrol product receives emergency market authorisation in France // A proven new solution to help winegrowers combat grapevine downy mildew
Amoéba receives emergency marketing authorization for AXPERA biocontrol product to combat grapevine downy mildew, helping French winegrowers against phytosanitary challenges
